|Year : 2018 | Volume
| Issue : 3 | Page : 171-173
Endobronchial metastasis of testicular germ cell tumor
Demet Turan1, Mehmet Akif Özgül1, Gamze Kirkil2, Erdogan Çetinkaya1
1 Department of Pulmonology, Yedikule Pulmonary Diseases and Thoracic Surgery Education and Research Hospital, Istanbul, Turkey
2 Department of Pulmonology, Faculty of Medicine, Firat University, Elazig, Turkey
|Date of Submission||03-Jul-2018|
|Date of Decision||09-Aug-2018|
|Date of Acceptance||10-Sep-2018|
|Date of Web Publication||31-Dec-2018|
Dr. Demet Turan
Belgrad Kapi Street No. 1, 34020 Istanbul
Source of Support: None, Conflict of Interest: None
Endobronchial metastasis (EBM) of extrapulmonary malignancies is rarely reported; on the other hand, germ cell tumors (GCTs) are extremely rare. This report describes a case of a testicular germ cell tumor presenting as a polypoid endobronchial mass. A 48-year-old male patient had a history of hemoptysis for several weeks. He had undergone orchiectomy due to testicular GCT 20 years ago. Computerized tomography of the thorax obtained endobronchial polypoid lesion in the right intermediate bronchus. Rigid bronchoscopy was applied; right intermediate bronchus was obliterated with a polypoid lesion. The lesion was coagulated with argon plasma coagulation, and debris was removed by biopsy forceps. Pathological examination of the specimen was somatic-type GCT. No recurrence was observed during the follow-up of the patient. We want to present our case to emphasize the importance of distinguishing EBM from primary lung carcinoma which treatment and survival are quite different.
Keywords: Endobronchial metastasis, germ cell tumors, intrabronchial therapy
|How to cite this article:|
Turan D, Özgül MA, Kirkil G, Çetinkaya E. Endobronchial metastasis of testicular germ cell tumor. Eurasian J Pulmonol 2018;20:171-3
| Introduction|| |
Pulmonary metastasis of extrapulmonary malignancies is frequent, but solitary endobronchial metastasis (EBM) is rarely reported. The prevalence of EBM is 2%–18% of all pulmonary metastasis. The most common sites for extragonadal germ cell tumors (GCTs) are the anterior mediastinum, the retroperitoneum, and the pineal and suprasellar regions. EBM of GCT is extremely rare, but mediastinal nodal enlargements due to testicular seminomas can be seen frequently. The rate of pulmonary metastases in testicular seminoma is approximately 15%.
Although the underlying causes may vary, most have similar symptoms such as cough, dyspnea, hemoptysis, and sputum. The treatment modality of EBM is dependent on many factors such as the histologic features of the primary tumor, biologic behavior, anatomic location, evidence of other metastatic sites, presenting symptoms, patient performance status, and life expectancy. For this reason, the accurate diagnosis of Endobronchial metastasis (EBM) is very important in deciding the appropriate treatment modality.
This report describes a case of a testicular GCT presenting as a polypoid endobronchial mass.
| Case Report|| |
A 48-year-old male patient referred to our clinic with a history of hemoptysis for several weeks. He had undergone orchiectomy due to testicular germ cell tumor 20 years ago. He also received adjuvant chemotherapy. He was a smoker with a history of 15 pack-years. His physical examination findings were unremarkable. Laboratory studies were normal. Chest radiography revealed right hilar enlargement [Figure 1]. Computerized tomography of the thorax obtained endobronchial polypoid lesion in the right intermediate bronchus [Figure 2]. Rigid bronchoscopy was applied; right intermediate bronchus was obliterated with a polypoid lesion [Figure 3]. The lesion was coagulated with repetitive argon plasma coagulation (APC), and debris was removed by biopsy forceps. After this implementation, cryo was applied to the lesion. Pathological examination of the lung bronchial biopsy specimen revealed malignant tumor with epithelial components, with extensive osseous and chondromatous mesenchymal elements. Results of immunohistochemistry staining were: pan-cytokeratin (+), protein 63 (P63) (+), Sal-like protein 4 (SALL4) (+), CD 99 (+), alpha-fetoprotein (+), glypican (+), vimentin (+), Tiroid transkripsiyon faktör-1 (TTF-1) (−), napsin-A (−), Cluster of Differantiation 30 (CD 30) (−), cytokeratin 20 (−), cytokeratin 20 (−), Epithelial membrane antigen (EMA) (−), Transducin-like enhancer protein 1 (TLE1) (−), and Octamer-binding transcription factor 4 (Oct-4) (−). After interpretation of these results, final diagnosis was confirmed as a somatic-type germ cell tumor. The patient was consulted to oncology department, and chemotherapy was started. No recurrence was observed in the 12th month of follow-up of the patient [Figure 4].
|Figure 2: Thorax computerized tomography showing endobronchial polypoid lesion in the right intermediary bronchus|
Click here to view
|Figure 3: Rigid bronchoscopic appearance of polypoid lesion in the right intermediate bronchus|
Click here to view
|Figure 4: Computerized tomography image after 12 months of endobronchial treatment|
Click here to view
| Discussion|| |
Lung metastases from extrapulmonary primary malignancies are frequent, but EBM is rare. Pulmonary metastasis is usually diagnosed by radiological methods. Therefore, bronchoscopic examination is not performed routinely for all patients presenting with pulmonary metastasis. This may lead to underdiagnosis of EBM. Frequently described primary malignancies which can lead to EBM include renal cell carcinoma, melanoma, breast cancer, thyroid carcinoma, colorectal adenocarcinoma, and cervical carcinoma. EBM due to testicular seminomas is extremely rare; for this reason, we want to present our case. Only a few reports of primary testicular seminoma causing EBM have been published until now.
As is seen with primary lung carcinomas, cough and hemoptysis are the most common symptoms in EBM. Lee et al. reported cough as the most common symptom. In our case, the only symptom was hemoptysis. We recommend bronchoscopic examination if there is one of these symptoms in a patient with known extrapulmonary malignancy.
Various radiologic findings may be present in patients with EBMs such as mediastinal lymphadenopathy, hilar masses, atelectasis, multiple pulmonary nodules, as well as normal chest radiography. In Lee et al.'s study, hilar mass, visible tumor, and atelectasis were common findings, but 9.3% of patients had normal chest X-rays. Therefore, it is important not to exclude symptomatic patients based solely on normal chest X-rays. Mediastinal lymphadenopathy is the most common intrathoracic manifestation of metastatic GCT as seen in our patient. Although EBM is often detected in the right side as seen in our patient, the reason of this predilection is not clear.
The presence of a bronchoscopically visible lesion in a patient with known extrapulmonary malignancy does not equal EBM since they are clinically, radiologically, and bronchoscopically indistinguishable from bronchogenic carcinoma in most cases. Histological analysis and the pathologic comparison of EBM and the primary site are important.
Interval between diagnosis of the primary tumor and the EBM is usually long and ranges from 0 to 65 months, depending on the biological behavior of primary tumor., Duration was so long in our patient; EMB occurred after 20 years. Survival is dependent on the primary tumor; 5-year survival in metastatic testicular carcinoma is approximately 82% in patients with lung metastases. The overall prognosis is poor (averaging 1–2 years) in most cases. The median survival was reported as 16.1 months in Lee et al.'s study, similar to the 15.5 months found by Kiryu et al., Molecular markers for genes that would explain the characteristics of these time intervals should be examined in future studies.
There are various treatment methods for EBM. Endobronchial treatment modalities such as mechanical resection, stent insertion, APC, cryotherapy, and laser evaporation have been performed for the management of these cases. These procedures are safe and effective as palliative treatment and can prolong survival in selected patients. Treatment of EBM must be planned according to the histology of the primary tumor, the location of the lesion in the bronchial tree, number of lesions, and medical status of the patient. In our patient, interventional bronchoscopy was the primary therapy. Palliative treatment with interventional bronchoscopy may also be effective in improving the quality of life in these patients by controlling hemoptysis and thus preventing asphyxia.
| Conclusion|| |
EBM of the GCTs is extremely rare. Hence, we want to present our case to emphasize the importance of distinguishing EBM from primary lung carcinoma which treatment and survival are quite different.
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Oshikawa K, Ohno S, Ishii Y, Kitamura S. Evaluation of bronchoscopic findings in patients with metastatic pulmonary tumor. Intern Med 1998;37:349-53.
Williams MP, Husband JE, Heron CW. Intrathoracic manifestations of metastatic testicular seminoma: A comparison of chest radiographic and CT findings. AJR Am J Roentgenol 1987;149:473-5.
Marchioni A, Lasagni A, Busca A, Cavazza A, Agostini L, Migaldi M, et al.
Endobronchial metastasis: An epidemiologic and clinicopathologic study of 174 consecutive cases. Lung Cancer 2014;84:222-8.
Lee SH, Jung JY, Kim DH, Lee SK, Kim SY, Kim EY, et al.
Endobronchial metastases from extrathoracic malignancy. Yonsei Med J 2013;54:403-9.
Díaz G, Jiménez D, Domínguez-Reboiras S, Carrillo F, Pérez-Rodríguez E. Yield of bronchoscopy in the diagnosis of neoplasm metastatic to lung. Respir Med 2003;97:27-9.
Kiryu T, Hoshi H, Matsui E, Iwata H, Kokubo M, Shimokawa K, et al.
Endotracheal/endobronchial metastases: Clinicopathologic study with special reference to developmental modes. Chest 2001;119:768-75.
Akoglu S, Uçan ES, Celik G, Sener G, Sevinç C, Kilinç O, et al
. Endobronchial metastases from extrathoracic malignancies. Clin Exp Metastasis 2005;22:587-91.
International germ cell consensus classification: A prognostic factor-based staging system for metastatic germ cell cancers. International germ cell cancer collaborative group. J Clin Oncol 1997;15:594-603.
Sørensen JB. Endobronchial metastases from extrapulmonary solid tumors. Acta Oncol 2004;43:73-9.
Fournel C, Bertoletti L, Nguyen B, Vergnon JM. Endobronchial metastases from colorectal cancers: Natural history and role of interventional bronchoscopy. Respiration 2009;77:63-9.
[Figure 1], [Figure 2], [Figure 3], [Figure 4]